Amanta Healthcare Limited (NSEI: AMANTA)
Health Care · Pharmaceuticals · IN
Rs156.33
-3.99% today · +10.3% 1Y
Amanta Healthcare Limited (NSEI: AMANTA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $56.13M.
Over the last twelve months the share price has gained 10.3%, trading between 92.00 and 189.00.
Tweenvest scores Amanta Healthcare Limited across four factors: quality 55/100, growth 17/100. Its strongest factor is quality.
AMANTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $56.13M
- Revenue (TTM)
- $30.80M
- P/E
- 39.30
- EPS
- 3.98
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs189.00
- 52-week low
- Rs92.00
- Avg volume (3M)
- —
- Shares outstanding
- 34.34M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.47 | +0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF375.40 | +0.43% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.86 | -0.72% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.